A versatile ultrafine and super-absorptive H(+)-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection.

A versatile ultrafine and super-absorptive H(+)-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection.
复制标题

一种多功能超细、高吸收性H()改性蒙脱石:用于代谢综合征干预和胃粘膜保护的应用。

DOI:
10.1039/d0bm00474j
复制
发表时间:
2020
期刊:
Biomater Sci
影响因子:
--
通讯作者:
Tang Guping
Tang Guping
中科院分区:
其他
文献类型:
--
作者:
Wang Qiwen;Shen Jie;Mo Enqi;Zhang Haotian;Wang Jianwei;Hu Xiurong;Zhou Jun;Bai Hongzhen;Tang Guping

文献摘要

相似文献

代谢综合征(MetS)包括向心性肥胖、高血压、胰岛素抵抗和血脂异常,与非酒精性脂肪肝、动脉粥样硬化性心血管疾病(CVD)和2型糖尿病密切相关,涉及多种致病因素。目前用于干预和改善MetS的药物疗法在代谢疾病的临床治疗中是必不可少的。在本报告中,我们提出了一种采用酸改性方法制备的H+改性蒙脱土(H-MMT),具有超细结构和超强吸收能力,作为治疗MetS的潜在药物。以高脂饮食喂养的仓鼠经口给予H-MMT,辛伐他汀作为对照。蒙脱土通过减少肠道吸收、促进脂质排泄来降低血脂,从而预防肥胖、脂肪肝和高脂血症。此外,与辛伐他汀相比,H-MMT明显更安全,肝脏耐受性更好,辛伐他汀具有肝毒性。此外,我们发现H-MMT对胃粘膜损伤有保护作用。因此,这种多功能的H-MMT提供了一种潜在的策略,以有效地改善代谢综合征,并在临床应用中提供胃粘膜保护。
Metabolic syndrome (MetS) includes central obesity, hypertension, insulin resistance, and dyslipidemia and is closely related to nonalcoholic fatty liver disease, atherosclerotic cardiovascular disease (CVD) and type 2 diabetes mellitus, involving multiple causative factors. Current drug therapies for intervention and amelioration of MetS are essential in clinical treatment of metabolic disease. In this report, we proposed an H+-modified montmorillonite (H-MMT) using an acid modification method with ultrafine structure and super absorption ability as a potential drug for MetS. Hamsters fed a high-fat diet were orally treated with H-MMT and simvastatin was applied as a control. H-MMT lowered lipids by decreasing intestinal absorption and promoting lipid excretion, subsequently preventing obesity, fatty liver, and hyperlipidemia. Moreover, H-MMT was significantly safer and better tolerated by the liver compared to simvastatin, which was hepatotoxic. In addition, we found that H-MMT had protective effects on gastric mucosal damage. Therefore, this versatile H-MMT provides a potential strategy to effectively improve MetS and provide gastric mucosal protection in clinical applications.